MC1881A1 - Derives de l'acide phosphinique - Google Patents

Derives de l'acide phosphinique

Info

Publication number
MC1881A1
MC1881A1 MC871933A MC1933A MC1881A1 MC 1881 A1 MC1881 A1 MC 1881A1 MC 871933 A MC871933 A MC 871933A MC 1933 A MC1933 A MC 1933A MC 1881 A1 MC1881 A1 MC 1881A1
Authority
MC
Monaco
Prior art keywords
acid derivatives
phosphinic acid
phosphinic
derivatives
acid
Prior art date
Application number
MC871933A
Other languages
English (en)
French (fr)
Inventor
John Broadhurst Michael
Krishan Handa Balraj
Henry Johnson William
Lawton Geoffrey
James Machin Peter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629876A external-priority patent/GB8629876D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1881A1 publication Critical patent/MC1881A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC871933A 1986-12-15 1987-12-10 Derives de l'acide phosphinique MC1881A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629876A GB8629876D0 (en) 1986-12-15 1986-12-15 Phosphinic acid derivatives
GB878722245A GB8722245D0 (en) 1986-12-15 1987-09-22 Phosphinic acid derivatives

Publications (1)

Publication Number Publication Date
MC1881A1 true MC1881A1 (fr) 1989-01-24

Family

ID=26291694

Family Applications (1)

Application Number Title Priority Date Filing Date
MC871933A MC1881A1 (fr) 1986-12-15 1987-12-10 Derives de l'acide phosphinique

Country Status (19)

Country Link
US (2) US4885283A (no)
EP (1) EP0276436B1 (no)
CN (1) CN1017337B (no)
AU (1) AU606901B2 (no)
CA (1) CA1326737C (no)
CS (1) CS272231B2 (no)
DE (1) DE3786250T2 (no)
DK (1) DK641687A (no)
ES (1) ES2056810T3 (no)
FI (1) FI89059C (no)
HU (1) HU203109B (no)
IE (1) IE62334B1 (no)
IL (1) IL84766A (no)
MC (1) MC1881A1 (no)
NO (1) NO171788C (no)
NZ (1) NZ222824A (no)
PH (1) PH25030A (no)
PT (1) PT86366B (no)
ZW (1) ZW23187A1 (no)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347840B1 (en) * 1988-06-23 1995-12-27 Banyu Pharmaceutical Co., Ltd. Phosphinic acid derivates
US5189178A (en) * 1990-11-21 1993-02-23 Galardy Richard E Matrix metalloprotease inhibitors
US5268384A (en) * 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
US5239078A (en) * 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
US5183900A (en) * 1990-11-21 1993-02-02 Galardy Richard E Matrix metalloprotease inhibitors
US5114953A (en) * 1990-11-21 1992-05-19 University Of Florida Treatment for tissue ulceration
CA2058797A1 (en) * 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives
FR2676059B1 (fr) * 1991-05-02 1993-07-23 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
EP0520573A1 (en) * 1991-06-27 1992-12-30 Glaxo Inc. Cyclic imide derivatives
CA2126687A1 (en) * 1992-01-15 1993-07-22 Charles G. Caldwell Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
US5326760A (en) * 1992-06-29 1994-07-05 Glaxo, Inc. Aminobutanoic acid compounds having metalloprotease inhibiting properties
US6037472A (en) * 1993-11-04 2000-03-14 Syntex (U.S.A.) Inc. Matrix metalloprotease inhibitors
AU5825094A (en) * 1993-11-19 1995-06-06 Astra Aktiebolag Novel dipeptide derivatives
GB9405076D0 (en) 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
US5476847A (en) * 1994-06-29 1995-12-19 Schering Corporation Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors
US5840698A (en) * 1994-10-27 1998-11-24 Affymax Technologies N.V. Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5831004A (en) * 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
US6011021A (en) * 1996-06-17 2000-01-04 Guilford Pharmaceuticals Inc. Methods of cancer treatment using naaladase inhibitors
FR2730235A1 (fr) * 1995-02-06 1996-08-09 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteur de l'endopeptidase a zinc 24-15
GEP20012388B (en) * 1995-12-08 2001-03-25 Agouron Pharma Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
PT780386E (pt) * 1995-12-20 2003-02-28 Hoffmann La Roche Inibidores de metaloprotease de matriz
US5795877A (en) * 1996-12-31 1998-08-18 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US6384022B1 (en) 1996-06-17 2002-05-07 Guilford Pharmaceuticals Inc. Prodrugs of NAALAdase inhibitors
US5863536A (en) * 1996-12-31 1999-01-26 Guilford Pharmaceuticals Inc. Phosphoramidate derivatives
US6054444A (en) 1997-04-24 2000-04-25 Guilford Pharmaceuticals Inc. Phosphonic acid derivatives
KR20000016750A (ko) 1996-06-17 2000-03-25 토마스 씨. 서 Naaladase 억제를 이용한 암의 치료방법.
US5977090A (en) * 1996-09-27 1999-11-02 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors
US6046180A (en) * 1996-06-17 2000-04-04 Guilford Pharmaceuticals Inc. NAALADase inhibitors
US5902817A (en) * 1997-04-09 1999-05-11 Guilford Pharmaceuticals Inc. Certain sulfoxide and sulfone derivatives
US5672592A (en) * 1996-06-17 1997-09-30 Guilford Pharmaceuticals Inc. Certain phosphonomethyl-pentanedioic acid derivatives thereof
US6025345A (en) * 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US6025344A (en) 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Certain dioic acid derivatives useful as NAALADase inhibitors
US6071965A (en) * 1996-06-17 2000-06-06 Guilford Pharmaceuticals Inc. Phosphinic alkanoic acid derivatives
PT923585E (pt) * 1996-07-18 2002-08-30 Pfizer Inibidores a base de fosfinato de metaloproteases de matriz
US6953788B1 (en) 1996-09-19 2005-10-11 Aventis Pharmaceuticals Inc. 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
US5962521A (en) * 1997-04-04 1999-10-05 Guilford Pharmaceuticals Inc. Hydroxamic acid derivatives
US6174915B1 (en) 1997-03-25 2001-01-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US6008243A (en) * 1996-10-24 1999-12-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
US5985900A (en) * 1997-04-01 1999-11-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US5981209A (en) * 1997-12-04 1999-11-09 Guilford Pharmaceuticals Inc. Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia
US6028216A (en) * 1997-12-31 2000-02-22 Guilford Pharmaceuticals Inc. Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives
US6121252A (en) * 1998-03-30 2000-09-19 Guilford Pharmaceuticals Inc. Phosphinic acid derivatives
US6329418B1 (en) 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
EP1093453B1 (en) 1998-07-06 2005-09-28 Guilford Pharmaceuticals Inc. Naaladase inhibitors useful as pharmaceutical compounds and compositions
US6265609B1 (en) 1998-07-06 2001-07-24 Guilford Pharmaceuticals Inc. Thio-substituted pentanedioic acid derivatives
US6395718B1 (en) * 1998-07-06 2002-05-28 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
HRP990246A2 (en) 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
NZ525513A (en) 1998-08-07 2004-09-24 Pont Pharmaceuticals Du Succinoylamino lactams as inhibitors of Abeta protein production
WO2000028331A1 (en) * 1998-11-12 2000-05-18 Du Pont Pharmaceuticals Company Use of radioligands to screen inhibitors of amyloid-beta peptide production
US6737038B1 (en) 1998-11-12 2004-05-18 Bristol-Myers Squibb Company Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
US6313159B1 (en) 1999-08-20 2001-11-06 Guilford Pharmaceuticals Inc. Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
GB9922577D0 (en) * 1999-09-23 1999-11-24 Center For Clinical & Basic Re Substituted phosphinate based peptide derivatives
US6696456B1 (en) * 1999-10-14 2004-02-24 The Procter & Gamble Company Beta disubstituted metalloprotease inhibitors
EP1265864A1 (en) 2000-03-21 2002-12-18 The Procter & Gamble Company Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
CA2401728A1 (en) * 2000-03-21 2001-09-27 The Procter & Gamble Company Difluorobutyric acid metalloprotease inhibitors
JP2003528078A (ja) * 2000-03-21 2003-09-24 ザ プロクター アンド ギャンブル カンパニー 炭素環式側鎖を含有するメタロプロテアーゼ阻害剤
BR0106717A (pt) 2000-06-01 2002-04-16 Bristol Myers Squibb Pharma Co Compostos, composição farmacêutica e usos dos compostos de lactama inovadora
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
WO2003104224A1 (en) 2002-06-10 2003-12-18 Pfizer Inc. Metabolites of prinomastat and their sythesis
JP6417421B2 (ja) 2014-02-28 2018-11-07 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． 荷電連結体及び共役体のためのその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226610A (en) * 1978-04-15 1980-10-07 Meiji Selka Kaisha, Ltd. Herbicidal compounds, preparation thereof and herbicides containing the same
JPS60163899A (ja) * 1984-02-03 1985-08-26 Sankyo Co Ltd レニン阻害ペプチド類
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
EP0209848A3 (en) * 1985-07-24 1988-07-27 Merck & Co. Inc. Enzyme inhibitors
EP0210545A3 (en) * 1985-07-24 1988-07-20 Merck & Co. Inc. Phosphorous containing enzyme inhibitors

Also Published As

Publication number Publication date
IL84766A0 (en) 1988-05-31
CA1326737C (en) 1994-02-01
EP0276436B1 (en) 1993-06-16
FI875484A0 (fi) 1987-12-14
CN87101164A (zh) 1988-06-29
PH25030A (en) 1991-01-28
NO171788B (no) 1993-01-25
FI89059C (fi) 1993-08-10
CS900287A2 (en) 1990-03-14
EP0276436A1 (en) 1988-08-03
DK641687D0 (da) 1987-12-07
NO171788C (no) 1993-05-05
CN1017337B (zh) 1992-07-08
US5006651A (en) 1991-04-09
US4885283A (en) 1989-12-05
CS272231B2 (en) 1991-01-15
NO875214L (no) 1988-06-16
IL84766A (en) 1994-02-27
FI89059B (fi) 1993-04-30
PT86366A (en) 1988-01-01
DE3786250T2 (de) 1993-10-07
NZ222824A (en) 1990-08-28
IE873383L (en) 1988-06-15
AU606901B2 (en) 1991-02-21
HU203109B (en) 1991-05-28
DK641687A (da) 1988-06-16
AU8217687A (en) 1988-06-16
DE3786250D1 (en) 1993-07-22
NO875214D0 (no) 1987-12-14
FI875484A (fi) 1988-06-16
ZW23187A1 (en) 1988-06-29
HUT46699A (en) 1988-11-28
ES2056810T3 (es) 1994-10-16
IE62334B1 (en) 1995-01-25
PT86366B (pt) 1990-11-20

Similar Documents

Publication Publication Date Title
MC1881A1 (fr) Derives de l'acide phosphinique
MA20648A1 (fr) Tensioactifs derives de l'acide citrique
DK434088D0 (da) Epipodophyllotoxinglucosid-4'-phosphatderivater
BE863429A (fr) Derives de l'acide quinoleine-carboxylique
DE68925240D1 (de) Phosphinsäure-Derivate
TR22942A (tr) Suebstituee edilmis pirimidin'ler
DK686487D0 (da) 1h-imidazol-5-carboxylsyrederivater
MC1512A1 (fr) Nouveaux derives d'acide phenoxyalkylcarboxylique
DK101287A (da) 1h-imidazol-5-carboxylsyrederivater
DK655487A (da) Furanuronsyrederivater
FR2640263B1 (fr) Preparation d'acide levulinique
MC1960A1 (fr) Derives d'acide hydrocinnamique
DK702688D0 (da) Epipodophyllotoxin-glucosid 4'-acylderivater
MA22543A1 (fr) Derives de l'acide propenoique
MC1848A1 (fr) Derives de l'isoprene
FR2580644B1 (fr) Derives de l'acide ascorbique
BE866900A (fr) Derives de l'acide 2-trichloromethyl-4-nitrobenzenesulfenique
FR2602233B1 (fr) Derives de l'isoquinoleine
FR2556346B1 (fr) Derives de l'acide malonyloxacepheme-carboxylique
FR2581645B1 (fr) Derives de l'acide octenoique
FR2541279B1 (fr) Derives de l'acide 1-aza-7-oxo-bicyclo(3.2.0)-hept-2-ene-2-carboxylique
DK403987D0 (da) Benzohydroxamsyrederivater
BE885656A (fr) Derives de l'acide oxayohimbane-carboxylique
FR2603282B1 (fr) Derives d'isoquinoleine
MC1816A1 (fr) Derives d'isoquinoleine

Legal Events

Date Code Title Description
YP Annual fee paid